Filing Details

Accession Number:
0001596783-17-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-27 11:02:19
Reporting Period:
2017-04-25
Filing Date:
2017-04-27
Accepted Time:
2017-04-27 11:02:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612208 Sharon Johnson C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-25 5,116 $10.71 26,781 No 4 M Direct
Common Stock Disposition 2017-04-25 3,407 $29.00 23,374 No 4 F Direct
Common Stock Disposition 2017-04-25 854 $29.00 22,520 No 4 S Direct
Common Stock Acquisiton 2017-04-25 31,150 $10.71 53,670 No 4 M Direct
Common Stock Disposition 2017-04-25 20,741 $29.00 32,929 No 4 F Direct
Common Stock Disposition 2017-04-25 5,204 $29.00 27,725 No 4 S Direct
Common Stock Acquisiton 2017-04-25 632 $18.57 28,357 No 4 M Direct
Common Stock Disposition 2017-04-25 512 $29.00 27,845 No 4 F Direct
Common Stock Disposition 2017-04-25 60 $29.00 27,785 No 4 S Direct
Common Stock Acquisiton 2017-04-25 3,850 $18.57 31,635 No 4 M Direct
Common Stock Disposition 2017-04-25 3,117 $29.00 28,518 No 4 F Direct
Common Stock Disposition 2017-04-25 366 $29.00 28,152 No 4 S Direct
Common Stock Acquisiton 2017-04-25 2,352 $18.57 30,504 No 4 M Direct
Common Stock Disposition 2017-04-25 1,904 $29.00 28,600 No 4 F Direct
Common Stock Disposition 2017-04-25 224 $29.00 28,376 No 4 S Direct
Common Stock Acquisiton 2017-04-25 9,352 $18.57 37,728 No 4 M Direct
Common Stock Disposition 2017-04-25 7,570 $29.00 30,158 No 4 F Direct
Common Stock Disposition 2017-04-25 891 $29.00 29,267 No 4 S Direct
Common Stock Acquisiton 2017-04-25 8,786 $18.71 38,053 No 4 M Direct
Common Stock Disposition 2017-04-25 7,135 $29.00 30,918 No 4 F Direct
Common Stock Disposition 2017-04-25 825 $29.00 30,093 No 4 S Direct
Common Stock Acquisiton 2017-04-25 9,478 $20.50 39,571 No 4 M Direct
Common Stock Disposition 2017-04-25 8,006 $29.00 31,565 No 4 F Direct
Common Stock Disposition 2017-04-25 736 $29.00 30,829 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase Common Stock Disposition 2017-04-25 5,116 $0.00 5,116 $10.71
Common Stock Options to purchase Common Stock Disposition 2017-04-25 31,150 $0.00 31,150 $10.71
Common Stock Options to purchase Common Stock Disposition 2017-04-25 2,352 $0.00 2,352 $18.57
Common Stock Options to purchase Common Stock Disposition 2017-04-25 9,352 $0.00 9,352 $18.57
Common Stock Options to purchase Common Stock Disposition 2017-04-25 632 $0.00 632 $18.57
Common Stock Options to purchase Common Stock Disposition 2017-04-25 3,850 $0.00 3,850 $18.57
Common Stock Options to purchase Common Stock Disposition 2017-04-25 8,786 $0.00 8,786 $18.71
Common Stock Options to purchase Common Stock Disposition 2017-04-25 9,478 $0.00 9,478 $20.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,150 2016-09-09 2019-10-23 No 4 M Direct
0 2016-09-09 2019-10-23 No 4 M Direct
0 2013-06-30 2022-06-30 No 4 M Direct
2,338 2022-06-30 No 4 M Direct
3,850 2016-09-09 2022-06-30 No 4 M Direct
0 2016-09-09 2022-06-30 No 4 M Direct
0 2014-06-25 2023-06-25 No 4 M Direct
9,478 2024-07-30 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2017 in order to implement a plan of financial diversification.
  2. Includes restricted stock units.
  3. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
  4. On June 30, 2012, the reporting person was granted an option to purchase 3,920 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2013, 2014, 2015, 2016 and 2017. The performance criteria for 2013, 2014 and 2015 were met, resulting in vesting of the option as to 2,352 shares in the aggregate.
  5. On June 30, 2012, the reporting person was granted an option to purchase 11,690 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on April 1, 2013.
  6. On June 25, 2013, the reporting person was granted an option to purchase 29,120 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018. The performance criteria for 2014 and 2015 were met, resulting in vesting of the option as to 11,648 shares in the aggregate.
  7. On July 30, 2014, the reporting person was granted an option to purchase 18,956 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 30, 2015.